Testing Experimental Medication in Healthy Subjects
common.study.values.description
“A Study of LY3478006 in Healthy Participants”
The purpose of this study is to learn more about how safe and how well tolerated LY3478006 is when given by injection into a vein or just under the skin to healthy participants. Blood tests will be done to check how much LY3478006 is in the bloodstream and how long the body takes to get rid of it. For each participant, the study will last up to about 16 weeks, including screening.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - LY3478006 - IV
Administered IV
Drug - LY3478006 - SC
Administered SC
Drug - Placebo - IV
Administered IV
Drug - Placebo - SC
Administered SC
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Single Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3478006 in Healthy Subjects
common.study.values.clinical-trial-id
NCT04230122
participant.views.study.view.id
aKrgze
